» Articles » PMID: 29130598

Filling the Periorbital Hollows with Hyaluronic Acid Gel: Long-term Review of Outcomes and Complications

Overview
Specialty Dermatology
Date 2017 Nov 14
PMID 29130598
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hyaluronic acid gel has been used for rejuvenation of the periorbital tissues since 2004. The in-office, nonsurgical procedural nature has resulted in the growing popularity of the use of fillers. The periorbital region poses unique challenges to the cosmetic surgeon. Malar edema, blue-gray dyschromia, and contour irregularities are well reported short-term complications. We present a long-term follow-up review of complications associated with periocular injection of hyaluronic acid gel fillers.

Methods: Retrospective review of 147 patients with at least a 5-year follow-up period since the first injection. Five senior masked reviewers were asked to grade photographs of patients in comparison with preinjection photographs. Grading was based on a reference photographic key looking specifically at the presence and severity of malar edema, blue-gray dyschromia, and contour irregularity.

Results: Malar edema (11%), blue-gray dyschromia (31.3%), and contour irregularities (30.5%) continue to be problems in longer term follow-up of patients. The vast majority (90%) of these complications were mild and required no intervention. There is no statistically significant difference in the mean volumes injected by severity grading of each measured complication.

Conclusion: Hyaluronic acid gel fillers of the periorbital region are well tolerated in our long-term follow-up experience. The vast majority of cases of malar edema, blue-gray dyschromia, and contour irregularities are mild and do not require intervention. Conservative treatment and tailored treatment approaches, in terms of volume and frequency of injections, may decrease the tendency of these adverse effects to occur.

Citing Articles

Fat or fillers: The dilemma in eyelid surgery.

Miotti G, De Marco L, Quaglia D, Grando M, Salati C, Spadea L World J Clin Cases. 2024; 12(17):2951-2965.

PMID: 38898854 PMC: 11185368. DOI: 10.12998/wjcc.v12.i17.2951.


Triamcinolone Injection in the Treatment of Malar Edema.

Baranska-Rybak W, Swierczewska Z, Lemiec A, Walker L Dermatol Pract Concept. 2024; 14(2).

PMID: 38810029 PMC: 11136127. DOI: 10.5826/dpc.1402a117.


The Posthyaluronidase Syndrome: Dosing Strategies for Hyaluronidase in the Dissolving of Facial Filler and Independent Predictors of Poor Outcomes.

Wilde C, Jiang K, Lee S, Ezra D Plast Reconstr Surg Glob Open. 2024; 12(4):e5765.

PMID: 38655103 PMC: 11037726. DOI: 10.1097/GOX.0000000000005765.


The Efficacy and Safety of Hyaluronic Acid Injection in Tear Trough Deformity: A Systematic Review and Meta-analysis.

Liu X, Gao Y, Ma J, Li J Aesthetic Plast Surg. 2023; 48(3):478-490.

PMID: 37684413 DOI: 10.1007/s00266-023-03613-7.


Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies.

Kyriazidis I, Spyropoulou G, Zambacos G, Tagka A, Rakhorst H, Gasteratos K Aesthetic Plast Surg. 2023; 48(4):719-741.

PMID: 37563436 DOI: 10.1007/s00266-023-03465-1.